161 related articles for article (PubMed ID: 30655752)
1. Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection.
Wu Y; Ren F; Chai Y; Xue Z; Shen C; Zhang X; Lv Y; Hu L
Oncol Lett; 2019 Jan; 17(1):165-174. PubMed ID: 30655752
[TBL] [Abstract][Full Text] [Related]
2. Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma.
Ohira M; Yoshizumi T; Yugawa K; Kosai-Fujimoto Y; Inokuchi S; Motomura T; Mano Y; Toshima T; Itoh S; Harada N; Ikegami T; Soejima Y; Taketomi A; Mori M
Surg Today; 2020 Apr; 50(4):379-388. PubMed ID: 31667580
[TBL] [Abstract][Full Text] [Related]
3. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection.
Zhang Y; Shi SM; Yang H; Yang LX; Wang Z; Li XD; Yin D; Shi YH; Cao Y; Dai Z; Zhou J; Chen Q
J Cancer; 2019; 10(2):494-503. PubMed ID: 30719145
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative inflammatory response biomarkers in patients undergoing curative thoracoscopic esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Nakada S; Ishibashi S; Tajima Y
Eur J Surg Oncol; 2017 Feb; 43(2):493-501. PubMed ID: 28034501
[TBL] [Abstract][Full Text] [Related]
6. Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma.
Lin J; Fang T; Zhu M; Xu X; Zhang J; Zheng S; Jing C; Zhang M; Liu B; Zhang B
Cancer Manag Res; 2019; 11():9107-9119. PubMed ID: 31802940
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment Inflammatory Indexes as Prognostic Predictors of Survival in Patients Suffering From Synovial Sarcoma.
Cheng Y; Mo F; Pu L; Li Q; Ma X
Front Oncol; 2019; 9():955. PubMed ID: 31608240
[No Abstract] [Full Text] [Related]
11. Prognostic Value of Inflammatory and Tumour Markers in Small-Duct Subtype Intrahepatic Cholangiocarcinoma after Curative-Intent Resection.
Ma B; Meng H; Shen A; Ma Y; Zhao D; Liu G; Zheng S; Tian Y; Zhang W; Li Q; Li S
Gastroenterol Res Pract; 2021; 2021():6616062. PubMed ID: 33833794
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
13. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy.
Shi S; Chen Q; Ye L; Yin D; Li X; Dai Z; He J
Oncotarget; 2017 Oct; 8(45):79366-79375. PubMed ID: 29108315
[TBL] [Abstract][Full Text] [Related]
15. Prognostic performance of inflammation-based prognostic indices in patients with resectable colorectal liver metastases.
Neal CP; Cairns V; Jones MJ; Masood MM; Nana GR; Mann CD; Garcea G; Dennison AR
Med Oncol; 2015 May; 32(5):144. PubMed ID: 25807934
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.
Peng J; Zhang R; Zhao Y; Wu X; Chen G; Wan D; Lu Z; Pan Z
Chin J Cancer; 2017 Dec; 36(1):96. PubMed ID: 29268783
[TBL] [Abstract][Full Text] [Related]
17. Prognostic utility of preoperative inflammatory markers in patients with intrahepatic cholangiocarcinoma after hepatic resection: A systematic review and meta-analysis.
Cui H; Li Y; Li S; Liu G
Cancer Med; 2023 Jan; 12(1):99-110. PubMed ID: 35692190
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value and model construction of preoperative inflammatory markers in patients with metastatic renal cell carcinoma.
Wang J; Ye J; Zhao X; Li X; Ma X
World J Surg Oncol; 2023 Jul; 21(1):211. PubMed ID: 37480143
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
Wang Y; Zhang H; Yang Y; Zhang T; Ma X
Front Oncol; 2019; 9():995. PubMed ID: 31649874
[No Abstract] [Full Text] [Related]
20. Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.
Kwon BS; Jeong DH; Byun JM; Lee TH; Choi KU; Song YJ; Suh DS; Kim KH
J Cancer; 2018; 9(7):1127-1134. PubMed ID: 29675093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
